Semler Scientific, Inc.
SMLRHealthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $56.3M | $68.2M | $56.7M | $53.0M | $38.6M | $32.8M |
| Operating income | $20.9M | $22.3M | $17.2M | $19.4M | $16.0M | $10.7M |
| Net income | $40.9M | $20.6M | $14.3M | $17.2M | $14.0M | $15.1M |
| Total assets | $239.8M | $78.1M | $62.7M | $50.7M | $34.6M | $18.3M |
| Total liabilities | — | — | — | — | — | — |
| Equity | $230.8M | $71.8M | $55.7M | $45.5M | $29.8M | $13.1M |
| EPS (diluted) | $5.13 | $2.63 | $1.79 | $2.12 | $1.74 | $1.88 |
| Shares out. | 7.0M | 6.8M | 6.8M | 6.7M | 6.5M | 6.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- 37.2%
- Net margin
- 72.7%
- Return on equity
- 17.7%
- Return on assets
- 17.1%
- Return on capital (ROCE)
- 9.0%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $32.82
- Revenue growth (YoY)
- −17.4%
- Net income growth (YoY)
- 98.7%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Accruals / assets
- 6.9%moderate
- Piotroski F-Score
- 3/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 warning● 3 good- Revenue declined year-over-year
- Operating margin is positive
- Strong return on equity (>15%)
- Positive operating cash flow
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Weiss Asset Management LpPassive (13G)May 11, 2026
- William H.C. Chang & Diana Shon Chang Ttee Chang Family Trust U/A Dtd 10/23/2006Activist (13D)Jan 16, 2026
- Semler EricActivist (13D)Jan 16, 2026
- Ridgeback Capital Investments L.P.Passive (13G)Nov 14, 2025
- Capital International InvestorsPassive (13G)Nov 13, 2025
- Capital Ventures InternationalPassive (13G)Nov 13, 2025
- Blackrock, Inc.Passive (13G)Oct 17, 2025
- Citadel Securities Gp LlcPassive (13G)Aug 14, 2025
- Morgan StanleyPassive (13G)Aug 7, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Jan 15, 2026 | 2.7M | 3.4 | -1.0% |
| Dec 31, 2025 | 2.8M | 6.8 | +0.1% |
| Dec 15, 2025 | 2.8M | 6.2 | +14.8% |
| Nov 28, 2025 | 2.4M | 5.3 | +8.8% |
| Nov 14, 2025 | 2.2M | 3.0 | +6.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsJan 16, 2026
- Shareholder voteJan 13, 2026
- Costs from exit or disposal · Other material eventDec 12, 2025
- Other material eventNov 14, 2025
- Regulation FD disclosure · Other material eventNov 12, 2025
- Other material eventNov 10, 2025
- Other material eventNov 6, 2025
- Director / officer changeOct 17, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13G/AMay 11, 2026
- SCHEDULE 13GFeb 11, 2026
- 15-12GFORM 15-12GJan 26, 2026
- EFFECTJan 21, 2026
- EFFECTJan 21, 2026
- S-8 POSFORM S-8 POSJan 16, 2026
- S-8 POSFORM S-8 POSJan 16, 2026
- S-8 POSFORM S-8 POSJan 16, 2026
- S-8 POSFORM S-8 POSJan 16, 2026
- S-8 POSFORM S-8 POSJan 16, 2026
- S-8 POSFORM S-8 POSJan 16, 2026
- POS AMFORM POS AMJan 16, 2026
- POS AMFORM POS AMJan 16, 2026
- 8-KFORM 8-KJan 16, 2026
- 4OWNERSHIP DOCUMENTJan 16, 2026
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.